Disease: Clinical Trials

12 trials for Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 unknown. 12 Phase 2, 4 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 212Unknown 12
Phase 14Unknown 4
Phase 34Unknown 4

Follow Disease: new trials by email Literature Review of Disease trials Research Report on Disease

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment
Treatment-specific InSight, InSight - Sepsis, Severe Sepsis
Phase 2UnknownDascena516452022-04-012021-09-23
Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study
Aveed 750 MG in 3 ML IM Injection, Normal Saline 3 ML IM Injection - Muscle Atrophy, Surgery
Phase 2 / Phase 3UnknownThe Stone Research Foundation for Sports Medicine and Arthritis152020-05-082021-08-31
Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT
Decitabine, Busulfan (BU), Cyclophosphamide (CY) - Allogeneic Hematopoietic Stem Cell Transplantation, Conditions
Phase 2 / Phase 3UnknownNanfang Hospital, Southern Medical University1222018-07-012018-07-24
CAR-T Cells for Relapsed or Refractory Haematopoietic and Lymphoid Malignancies
Autologous CAR-T cells - Leukemia, Lymphoma
Phase 1 / Phase 2UnknownHebei Senlang Biotechnology Inc., Ltd.502017-08-292019-01-09
Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22
anti-CD19/22-CAR vector-transduced T cells - Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2UnknownChinese PLA General Hospital302017-08-012019-04-17
Basiliximab Treating Interstitial Pneumonia of CADM
Basiliximab, Calcineurin Inhibitors, Steroids - Lung; Disease, Interstitial, With Fibrosis, Dermatomyositis
Phase 2UnknownRenJi Hospital1002017-07-012017-06-20
Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of AIR DNase™in Patients With Cystic Fibrosis Previously Treated With Pulmozyme®
AIR DNase™ - Cystic Fibrosis
Phase 2UnknownProtalix152016-05-012016-09-28
Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome
benralizumab, Placebo - Respiratory System Agents, Anti-Asthmatic Agents
Phase 2 / Phase 3UnknownNational Institute of Allergy and Infectious Diseases (NIAID)202014-05-192022-02-08
Dementia Early Recognition and Response in Primary Care
Educational Dementia training - Dementia
Phase 2 / Phase 3UnknownUniversity College, London1252009-07-012010-04-19
A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma
Temozolomide - Glioma
Phase 2UnknownKentuckiana Cancer Institute202009-01-012010-01-20
Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease
Endoscopic Mucosal Resection (EMR) - Chronic Constipation, Hirschsprung's Disease
Phase 1 / Phase 2UnknownMassachusetts General Hospital502007-10-012008-05-05
Use of Hair to Diagnose the Presence of Breast Cancer
diagnosis of breast cancer by x-ray diffraction of hair - Breast Cancer
Phase 1 / Phase 2UnknownFermiscan Ltd20002006-12-012007-01-09

Narrower conditions

Breast Neoplasms (1)  ·  Constipation (1)  ·  Cystic Fibrosis (1)  ·  Dementia (1)  ·  Dermatomyositis (1)  ·  Digestive System Diseases (1)  ·  Eosinophilia (1)  ·  Eosinophilic Esophagitis (1)  ·  Genetic Diseases, Inborn (1)  ·  Glioma (1)  ·  Hematologic Diseases (1)  ·  Hematologic Neoplasms (1)  ·  Hirschsprung Disease (1)  ·  Knee Injuries (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (12)  ·  Pathologic Processes (11)  ·  Neoplasms (4)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Neoplasms by Histologic Type (3)  ·  Nervous System Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Digestive System Diseases (2)  ·  Gastrointestinal Diseases (2)  ·  Hematologic Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms by Site (2)

Interventions

Basiliximab (1)  ·  Busulfan (1)  ·  Calcineurin Inhibitors (1)  ·  Cyclophosphamide (1)  ·  Decitabine (1)  ·  Endoscopic Mucosal Resection (1)  ·  Injections, Intramuscular (1)  ·  Saline Solution (1)  ·  Steroids (1)  ·  Temozolomide (1)  ·  Testosterone Propionate (1)  ·  benralizumab (1)

Sponsors

Chinese PLA General Hospital (1)  ·  Dascena (1)  ·  Fermiscan Ltd (1)  ·  Hebei Senlang Biotechnology Inc., Ltd. (1)  ·  Kentuckiana Cancer Institute (1)  ·  Massachusetts General Hospital (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Protalix (1)  ·  RenJi Hospital (1)  ·  The Stone Research Foundation for Sports Medicine and Arthritis (1)  ·  University College, London (1)

Countries

China (4)  ·  United States (4)  ·  Australia (1)  ·  Israel (1)  ·  United Kingdom (1)

Top investigators

Amy D Klion, M.D. (1)  ·  Braden Kuo, MD (1)  ·  Clarissa Foy, NP (1)  ·  Einat Dekel, DVM (1)  ·  Field F Willingham, MD, MPH (1)  ·  Garrett C Zella, MD (1)  ·  Jane Wilcock, MA(hons) MSc (1)  ·  Leonel Rodriguez, MD (1)  ·  Mani Vessal, Ph.D. (1)  ·  Mari Mino-Kenudson, MD (1)  ·  Peggy Lu, PhD & MD (1)  ·  Phillip Yuile, MBBS, FRACR (1)  ·  Qifa Liu (1)  ·  Qingqing Mao, PhD (1)  ·  Renato V LaRocca, MD (1)

Results publications

PMID 20146803, PMID 24257429, PMID 32245502, PMID 35283330, PMID 40120806